BONG, S.-T.; LAW, L. N.-S.; LAW, J. W.-F. A review on the potential of Bruton’s tyrosine kinase (Btk) inhibitor – Ibrutinib for treatment of Multiple Myeloma (MM). Progress In Microbes & Molecular Biology, [S. l.], v. 2, n. 1, 2019. DOI: 10.36877/pmmb.a0000028. Disponível em: https://hh-publisher.com/ojs321/index.php/pmmb/article/view/60. Acesso em: 18 nov. 2024.